Nemo Marjanovic

Nemo Marjanovic is currently a Senior Associate at Northpond Ventures, a venture capital firm executing science-driven investments across the global healthcare sector. Operating as a key investment professional within the organization, his scope of work involves evaluating and supporting early-stage transactions across biotechnology, advanced diagnostics, digital health, and environmental solutions. Marjanovic recently contributed to the firm's financial backing of EnPlusOne Biosciences, a life sciences entity that secured an initial $10.0 million venture round on February 1, 2025, followed by an additional $10.0 million in other equity financing on February 19, 2025. Through these specific transactions, his investment activities frequently involve collaborating with specialized industry peers, including co-investors such as Breakout Ventures. Marjanovic's current professional focus remains strictly centered on deploying capital to scale science-driven enterprises within the broader life sciences and affiliated biotechnology industries.